Carroll Financial Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | $90K | Sell |
143
-3
| -2% | -$1.89K | ﹤0.01% | 554 |
|
2021
Q3 | $88K | Buy |
146
+7
| +5% | +$4.22K | ﹤0.01% | 568 |
|
2021
Q2 | $77K | Buy |
139
+6
| +5% | +$3.32K | ﹤0.01% | 663 |
|
2021
Q1 | $62K | Sell |
133
-2
| -1% | -$932 | ﹤0.01% | 712 |
|
2020
Q4 | $65K | Buy |
135
+83
| +160% | +$40K | ﹤0.01% | 629 |
|
2020
Q3 | $29K | Hold |
52
| – | – | ﹤0.01% | 778 |
|
2020
Q2 | $32K | Sell |
52
-723
| -93% | -$445K | ﹤0.01% | 760 |
|
2020
Q1 | $378K | Buy |
775
+723
| +1,390% | +$353K | 0.04% | 227 |
|
2019
Q4 | $19K | Sell |
52
-15
| -22% | -$5.48K | ﹤0.01% | 894 |
|
2019
Q3 | $18K | Hold |
67
| – | – | ﹤0.01% | 858 |
|
2019
Q2 | $20K | Sell |
67
-577
| -90% | -$172K | ﹤0.01% | 831 |
|
2019
Q1 | $264K | Buy |
644
+577
| +861% | +$237K | 0.02% | 282 |
|
2018
Q4 | $26K | Hold |
67
| – | – | ﹤0.01% | 608 |
|
2018
Q3 | $27K | Hold |
67
| – | – | ﹤0.01% | 634 |
|
2018
Q2 | $23K | Hold |
67
| – | – | ﹤0.01% | 642 |
|
2018
Q1 | $23K | Hold |
67
| – | – | ﹤0.01% | 634 |
|
2017
Q4 | $25K | Hold |
67
| – | – | ﹤0.01% | 608 |
|
2017
Q3 | $31K | Sell |
67
-15
| -18% | -$6.94K | ﹤0.01% | 572 |
|
2017
Q2 | $40K | Hold |
82
| – | – | ﹤0.01% | 540 |
|
2017
Q1 | $31K | Hold |
82
| – | – | ﹤0.01% | 571 |
|
2016
Q4 | $30K | Sell |
82
-20
| -20% | -$7.32K | ﹤0.01% | 557 |
|
2016
Q3 | $41K | Hold |
102
| – | – | 0.01% | 497 |
|
2016
Q2 | $35K | Hold |
102
| – | – | 0.01% | 508 |
|
2016
Q1 | $36K | Hold |
102
| – | – | 0.01% | 489 |
|
2015
Q4 | $55K | Sell |
102
-10
| -9% | -$5.39K | 0.01% | 384 |
|
2015
Q3 | $58K | Hold |
112
| – | – | 0.01% | 365 |
|
2015
Q2 | $57K | Buy |
112
+100
| +833% | +$50.9K | 0.01% | 344 |
|
2015
Q1 | $5K | Hold |
12
| – | – | ﹤0.01% | 639 |
|
2014
Q4 | $5K | Sell |
12
-100
| -89% | -$41.7K | ﹤0.01% | 583 |
|
2014
Q3 | $44K | Hold |
112
| – | – | 0.01% | 326 |
|
2014
Q2 | $32K | Hold |
112
| – | – | 0.01% | 386 |
|
2014
Q1 | $34K | Buy |
112
+12
| +12% | +$3.64K | 0.01% | 349 |
|
2013
Q4 | $27K | Hold |
100
| – | – | 0.01% | 372 |
|
2013
Q3 | $31K | Hold |
100
| – | – | 0.01% | 358 |
|
2013
Q2 | $22K | Buy |
+100
| New | +$22K | 0.01% | 321 |
|